Skip to content
HowShorted

TherapeuticsMD, Inc. short interest in 2021

In 2021, TherapeuticsMD, Inc.'s disclosed short interest ran from 24.21% of shares outstanding on 15 Jan 2021 to 4.41% on 31 Dec 2021, a change of -19.80 percentage points. The year's high was 26.64% on 12 Feb 2021 and its low 4.41% on 31 Dec 2021, averaging 12.50% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.91 days on 15 Jan 2021. Full history: TherapeuticsMD, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TherapeuticsMD, Inc. in 2021

2021 in figures

Start of year
24.21% (15 Jan 2021)
End of year
4.41% (31 Dec 2021)
Change
-19.80 pp
High
26.64% (12 Feb 2021)
Low
4.41% (31 Dec 2021)
Average
12.50%
Highest days to cover
12.91 (15 Jan 2021)
SEC filings marked
8

Every report in 2021

TherapeuticsMD, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202124.21%12.91
29 Jan 202124.01%6.94
12 Feb 202126.64%2.82
26 Feb 202120.43%3.74
15 Mar 202114.84%3.04results (8-K), 10-K filed
31 Mar 202115.40%6.62
15 Apr 202116.67%8.23
30 Apr 202116.68%8.67
14 May 202116.00%6.9710-Q filed, results (8-K)
28 May 202115.38%11.20
15 Jun 202114.60%10.71
30 Jun 202114.44%11.71
15 Jul 20218.77%4.42
30 Jul 20218.34%8.37
13 Aug 20215.33%4.8710-Q filed, results (8-K)
31 Aug 20215.44%3.05
15 Sep 20216.77%5.41
30 Sep 20216.82%5.05
15 Oct 20216.71%9.70
29 Oct 20216.87%10.69
15 Nov 20217.10%7.5810-Q filed, results (8-K)
30 Nov 20217.81%5.13
15 Dec 20216.25%3.51
31 Dec 20214.41%3.64

See also: TherapeuticsMD, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.